5th Annual
Brain Tumor Symposium
PAID
PERMIT NO. #117
SOUTHEASTERN, PA
19399
The New Revolution in Neuro-Oncology:
Molecular Diagnoses and Targeted Treatments
NON-PROFIT ORG
U.S. POSTAGE
5th Annual Brain Tumor Symposium
Friday, October 30, 2015 | DoubleTree by Hilton Hotel Philadelphia Center City
237 South Broad Street, Philadelphia, PA 19107
The New Revolution in Neuro-Oncology:
Molecular Diagnoses and Targeted Treatments
Registration Fees
Practicing Physician
$165
Nurse / Nurse Practitioner
$140
Allied Health Professional
$140
Jefferson Affiliate Hospitals - Practicing Physician
$125
Jefferson Affiliate Hospitals - Nurse / Allied Health Professional
$105
Non-Jefferson Resident
$100
Non-Jefferson Fellow
$100
ATION
REGISTR
N OW !
OPEN
The registration fee includes all course materials, access to presentations online, CE certificate, breakfast,
refreshment breaks and lunch. The registration fee does not include parking.
HOME
CME ACTIVITIES
| Sidney Kimmel Medical College
RSS/GRAND ROUNDS
LEARNING GROUPS
CREDIT HISTORY
CONTACT US
*Registration Deadline is: October 28, 2015*
Registrations should be submitted online by this date. Registrations cannot be processed without payment.
Should you need additional assistance or if you have any special needs, please contact the Office of CME at
215-955-6992 or via email at jeffersoncme@Jefferson.edu. Paper registration available upon request.
Department of Neurological Surgery
As an integral part of Jefferson Hospital for Neuroscience, the region’s only dedicated hospital for neuroscience,
the Department of Neurological Surgery is one of the busiest academic neurosurgical programs in the country,
offering state-of-the-art treatment to patients with neurological diseases affecting the brain and spine, such
as brain tumors, spinal disease, vascular brain diseases, epilepsy, pain, Parkinson’s disease and many other
neurological disorders. Jefferson.edu/university/jmc/departments/neurosurgery.html
Registration Now Open!
Thomas Jefferson University
Register
Office of Continuing Medical Education
1020 Locust Street, Suite M-5
Philadelphia, PA 19107
Log in
Have a smart phone?
Go to scanlife.com
to download your free
QR code reader
Step #2 – Once you are logged in, you may register for this conference by clicking the “CME Activities” tab
located on the top of the page, and clicking on the activity name “5th Annual Brain Tumor Symposium”.
• Review the course webpage, and scroll down to see the registration options.
• Complete the online registration process.
• You will receive a confirmation email of your successful registration.
• If you are unable to attend, cancellation fees may be applied. Please refer to the Cancellation/Refund
Policy located on the course webpage at CME.Jefferson.edu.
Friday, October 30, 2015
Step #1 – Login to your account on CPD@JeffLearn™ at CME.Jefferson.edu.
• If you do not have an account, step by step instructions can be found on the CPD@JeffLearn™ webpage.
• Click “Login” if you have an account. Click “Register” to create an account
The New Revolution in Neuro-Oncology:
Molecular Diagnoses and Targeted Treatments
Important Browser Information – site works best on Google CHROME, Mozilla FIREFOX, SAFARI or OPERA.
Please be sure you are running the most recent version of your browser.
5th Annual Brain Tumor Symposium
Here’s How to Register Online Today at CME.Jefferson.edu:
Friday, October 30, 2015
DoubleTree by Hilton Hotel Philadelphia Center City
Featured Guest Speakers
Tracy T. Batchelor, MD, MPH
Jason T. Huse, MD, PhD
Frederick F. Lang, Jr, MD, FACS, FAANS
5th Annual Brain Tumor Symposium
The New Revolution in Neuro-Oncology:
Molecular Diagnoses and Targeted Treatments
Friday, October 30, 2015 | DoubleTree by Hilton Hotel Philadelphia Center City
237 South Broad Street, Philadelphia, PA 19107
Course Description
This CME Conference offers participants a unique opportunity to hear expert clinician leaders relate
their knowledge of the field of neuro-oncology and current state-of-the-art advances. Cases will be
examined from multiple perspectives, providing participants with clinical pearls for diagnosing and
managing malignant brain tumors to improve patient outcomes.
The course will feature:
• M
orning lectures devoted to the theme of the symposium: new research initiatives that highlight
the dramatic advances in both diagnosis and treatment of malignant brain tumors.
Friday, October 30, 2015
(Preliminary Agenda/Subject to Change)
7:00AMRegistration, Continental Breakfast,
and Exhibits
7:45AMWelcome & Introduction of
Keynote Speakers
David W. Andrews, MD, FACS
Lyndon J. Kim, MD
8:00AM
Keynote Lecture: Exploiting Viruses and
Stem Cells for Glioma Therapy
Frederick F. Lang, Jr, MD, FACS, FAANS
Introduction: Kevin D. Judy, MD, FACS
8:40AM
• A
fternoon, profession-specific break-out sessions, providing additional opportunities for focused
discussions and interactions.
Each session will be designed to give practitioners updates in the latest trends and advances in
neuro-oncology and learning will be reinforced through lively interactive case-based discussion.
Lectures will also provide practitioners with updates in ongoing clinical trials at Jefferson as well as
current outpatient brain tumor management.
Educational Design
At the conclusion of this conference, participants should be able to:
ƒƒ Examine how viruses work and how they can
be engineered for glioma therapy.
ƒƒ Describe how molecular markers refine the
diagnosis and management of diffuse glioma
and evaluate their impact on both prognosis
and treatment.
ƒƒ Assess the plight of orphan diseases and the
challenges of establishing evidence-based
treatment data for small patient populations.
ƒƒ Appraise the literature and the WHO Classification
System for common brain tumors and cite
sources where new knowledge has modified or
changed the classification of certain tumors.
ƒƒ Recognize how molecular markers refine the
diagnosis and management of brain metastases ƒƒ Summarize the history of human experimentation
from systemic cancers and evaluate their
spanning from the mid-20th century to the
impact on both prognosis and treatment.
present and draw conclusions about evolution of
FDA regulations for human research.
ƒƒ Review and critique current treatment
strategies for CNS lymphoma and evaluate the ƒƒ Evaluate current clinical trials at Jefferson as it
metrics for establishing a cure for this disease.
relates to patient centric care and validate the
process for enrollment criteria for each trial.
ƒƒ Examine how the current standard of care
treatment negatively impacts the immune system ƒƒ Differentiate various radiation treatment methods
and how this might influence an immunotherapy
currently utilized for benign and malignant
treatment for recurrent glioma treatment.
disease and evaluate patient centric care needs,
both during and after radiation therapy.
ƒƒ Analyze the challenging anatomy of the sellar
region and appreciate how recent innovations ƒƒ Analyze the detailed nature of outpatient care
in treatment and outcomes have improved
of brain tumor patients and identify the tools to
patient care.
determine the individual needs of patients and
families, particularly during treatment.
ƒƒ Appraise the methodology and technology
of new fiberoptic laser technology and its
ƒƒ Assess their individual practice in light of the
application to challenging lesions such as
information and discussions during the course,
“butterfly” gliomas.
and identify specific strategies to implement as
part of a continuing improvement process for
their practices.
eynote Lecture: The Evolving Role of
K
Molecular Markers in the Diagnosis and
Management of Diffuse Gliomas
Jason T. Huse, MD, PhD
Keynote Lecture: Targeted Therapeutics
for Gliomas
Tracy T. Batchelor, MD, MPH
Introduction: Lyndon J. Kim, MD
9:20AM
10:00AMBreak & Exhibits
10:20AMUpdate for IND 14379-101: Immunotherapy
Trial for Recurrent Glioma
David W. Andrews, MD, FACS
10:50AMChemotherapy Redux: Resurrecting PCV
Chemotherapy for Oligodendroglioma
Jon Glass, MD
1:45PMApplication of Fiber-Optic Laser to
Malignant Intracranial Disease
Kevin D. Judy, MD, FACS
2:15PMReview of New Protocols for
Craniopharyngioma and WHO
Grade II Meningioma
Christopher J. Farrell, MD
3:00PMUtilization of Molecular Genetic Profiling Test
to Individualize Chemotherapy Treatment
Lyndon J. Kim, MD
3:30PMAnticipating the 2016 WHO Fascicle on Brain
Tumors: An Update
Lawrence C. Kenyon, MD, PhD
Nurse And Allied Health Professional Track:
Updates From Jefferson Nurses
ORCHESTRA BALLROOM
1:15PMWhen is a Novel Treatment Innovative and
When is it Experimental?
Catherine Harris, PhD, MBA, CRNP
1:45PMUpdate on Current Clinical Neuro-Oncology
Trials at Jefferson
Lauren Barbieri, CRNP
1:15PM
Break/Move to Breakout Session
3:30PMInteractive Discussion: Case Presentations
Two Afternoon Break-Out Sessions: Practicing
and Question/Answer
Physician Track and Nurses/Allied Health
Moderator: Lauren Barbieri, CRNP
Professionals Track. All attendees will re-convene Panelists: S akinah Abdulkhabir, RN, BSN
after the afternoon break-out sessions for the
Catherine Harris, PhD, MBA, CRNP
Closing Remarks in the Symphony Ballroom.
Gail Williams, DNP, CRNP, AOCNP
SYMPHONY BALLROOM
David W. Andrews, MD, FACS
James J. Evans, MD, FACS
Professor of Neurological Surgery
Vice Chair, Clinical Services
Department of Neurological Surgery
Division Chief, Division of Neuro-Oncology
Professor of Neurological Surgery and
Otolaryngology – Head and Neck Surgery
Director, Cranial Base and Pituitary Surgery
Co-Director, Jefferson Center for Minimally Invasive
Cranial Base and Endoscopic Neurosurgery
Lauren Barbieri, CRNP
Nurse Practitioner
Department of Neurological Surgery
FINAL PLENARY SESSION
4:00PMClosing Remarks
David W. Andrews, MD, FACS
1:15PMUpdate in Minimally Invasive Cranial
Base Surgery
James J. Evans, MD, FACS
For additional information please visit CME.Jefferson.edu
Kevin D. Judy, MD, FACS
Professor of Neurological Surgery
Section Chief, Surgical Neuro-Oncology
Guest Faculty
2:45PMBreak & Exhibits
2:15PMRadiation Therapy WBRT/SRS: Nursing
Overview of the Radiation Treatment
11:20AMPanel of Invited Speakers: A Discussion of
Methods for Brain Tumors
Selected Cases from the Faculty
Gail Williams, DNP, CRNP, AOCNP
Moderator: David W. Andrews, MD, FACS
Panelists: T racy T. Batchelor, MD, MPH
2:45PMBreak & Exhibits
Jason T. Huse, MD, PhD
Frederick F. Lang, Jr, MD, FACS, FAANS 3:00PMNursing Management of Patients with Brain
Tumors in Ambulatory Care
12:30PM Lunch & Exhibits
Sakinah Abdulkhabir, RN, BSN
Practicing Physician Track:
Updates From Jefferson Physicians
Sidney Kimmel Medical College Course Directors
Tracy T. Batchelor, MD, MPH
Giovanni Armenise - Harvard Professor of Neurology, Harvard Medical School
Executive Director, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital
Boston, Massachusetts
Jason T. Huse, MD, PhD
Assistant Member, Department of Pathology and Human Oncology and Pathogenis Program
Memorial Sloan-Kettering Cancer Center
New York, New York
Frederick F. Lang, Jr, MD, FACS, FAANS
Professor of Neurosurgery
Director of Clinical Research, Department of Neurosurgery, Division of Surgery
The University of Texas MD Anderson Cancer Center
Houston, TX
Sidney Kimmel Medical College Faculty
Sakinah Abdulkhabir, RN, BSN
Lawrence Kenyon, MD, PhD
Nurse, Department of Neurological Surgery
Associate Professor of Pathology, Anatomy,
Cell Biology, and Neurology
Christopher Farrell, MD
Associate Professor of Neurological Surgery
Lyndon Kim, MD
Jon Glass, MD
Associate Professor of Medical Oncology
and Neurological Surgery
Associate Professor of Neurology and Neurological Surgery
Catherine Harris, PhD, MBA, CRNP
Assistant Professor, Graduate Program
Jefferson College of Nursing
Gail Williams DNP, CRNP, AOCNP
Nurse Practitioner, Department of Neurological Surgery
For more information, please visit the course web page: CME.Jefferson.edu
ACCREDITATION INFORMATION
PHYSICIANS: Sidney Kimmel Medical College at Thomas
Jefferson University is accredited by the ACCME to
provide continuing medical education for physicians.
Sidney Kimmel Medical College designates this live activity
for a maximum of 6.75 AMA PRA Category 1 CreditsTM.
Physicians should claim only the credit commensurate
with the extent of their participation in the activity.
NURSES: Thomas Jefferson University Hospital is an approved
provider of continuing nursing education by the PA State
Nurses Association, an accredited approver by the American
Nurses Credentialing Center’s Commission on Accreditation.
A maximum of 6.66 contact hours will be awarded to
participants.
PHYSICIAN ASSISTANTS: The American Academy of
Physician Assistants accepts AMA PRA Category 1
Credit(s)™ (www.aapa.org).
FACULTY DISCLOSURE
All faculty participating in continuing medical education
activities sponsored by Sidney Kimmel Medical College
at Thomas Jefferson University are expected to disclose
to the activity audience any real or apparent conflict(s)
of interest related to the content of their presentation(s).
Full disclosure of faculty relationships will be made at the
activity.
HOTEL ACCOMMODATIONS
Please visit the course web page for hotel accommodation
information.
In keeping with Jefferson’s integrated approach to education and care, this Symposium is organized through the collaborative
efforts of Jefferson’s Sidney Kimmel Cancer Center, and Sidney Kimmel Medical College at Thomas Jefferson University.
5th Annual Brain Tumor Symposium
The New Revolution in Neuro-Oncology:
Molecular Diagnoses and Targeted Treatments
Friday, October 30, 2015 | DoubleTree by Hilton Hotel Philadelphia Center City
237 South Broad Street, Philadelphia, PA 19107
Course Description
This CME Conference offers participants a unique opportunity to hear expert clinician leaders relate
their knowledge of the field of neuro-oncology and current state-of-the-art advances. Cases will be
examined from multiple perspectives, providing participants with clinical pearls for diagnosing and
managing malignant brain tumors to improve patient outcomes.
The course will feature:
• M
orning lectures devoted to the theme of the symposium: new research initiatives that highlight
the dramatic advances in both diagnosis and treatment of malignant brain tumors.
Friday, October 30, 2015
(Preliminary Agenda/Subject to Change)
7:00AMRegistration, Continental Breakfast,
and Exhibits
7:45AMWelcome & Introduction of
Keynote Speakers
David W. Andrews, MD, FACS
Lyndon J. Kim, MD
8:00AM
Keynote Lecture: Exploiting Viruses and
Stem Cells for Glioma Therapy
Frederick F. Lang, Jr, MD, FACS, FAANS
Introduction: Kevin D. Judy, MD, FACS
8:40AM
• A
fternoon, profession-specific break-out sessions, providing additional opportunities for focused
discussions and interactions.
Each session will be designed to give practitioners updates in the latest trends and advances in
neuro-oncology and learning will be reinforced through lively interactive case-based discussion.
Lectures will also provide practitioners with updates in ongoing clinical trials at Jefferson as well as
current outpatient brain tumor management.
Educational Design
At the conclusion of this conference, participants should be able to:
ƒƒ Examine how viruses work and how they can
be engineered for glioma therapy.
ƒƒ Describe how molecular markers refine the
diagnosis and management of diffuse glioma
and evaluate their impact on both prognosis
and treatment.
ƒƒ Assess the plight of orphan diseases and the
challenges of establishing evidence-based
treatment data for small patient populations.
ƒƒ Appraise the literature and the WHO Classification
System for common brain tumors and cite
sources where new knowledge has modified or
changed the classification of certain tumors.
ƒƒ Recognize how molecular markers refine the
diagnosis and management of brain metastases ƒƒ Summarize the history of human experimentation
from systemic cancers and evaluate their
spanning from the mid-20th century to the
impact on both prognosis and treatment.
present and draw conclusions about evolution of
FDA regulations for human research.
ƒƒ Review and critique current treatment
strategies for CNS lymphoma and evaluate the ƒƒ Evaluate current clinical trials at Jefferson as it
metrics for establishing a cure for this disease.
relates to patient centric care and validate the
process for enrollment criteria for each trial.
ƒƒ Examine how the current standard of care
treatment negatively impacts the immune system ƒƒ Differentiate various radiation treatment methods
and how this might influence an immunotherapy
currently utilized for benign and malignant
treatment for recurrent glioma treatment.
disease and evaluate patient centric care needs,
both during and after radiation therapy.
ƒƒ Analyze the challenging anatomy of the sellar
region and appreciate how recent innovations ƒƒ Analyze the detailed nature of outpatient care
in treatment and outcomes have improved
of brain tumor patients and identify the tools to
patient care.
determine the individual needs of patients and
families, particularly during treatment.
ƒƒ Appraise the methodology and technology
of new fiberoptic laser technology and its
ƒƒ Assess their individual practice in light of the
application to challenging lesions such as
information and discussions during the course,
“butterfly” gliomas.
and identify specific strategies to implement as
part of a continuing improvement process for
their practices.
eynote Lecture: The Evolving Role of
K
Molecular Markers in the Diagnosis and
Management of Diffuse Gliomas
Jason T. Huse, MD, PhD
Keynote Lecture: Targeted Therapeutics
for Gliomas
Tracy T. Batchelor, MD, MPH
Introduction: Lyndon J. Kim, MD
9:20AM
10:00AMBreak & Exhibits
10:20AMUpdate for IND 14379-101: Immunotherapy
Trial for Recurrent Glioma
David W. Andrews, MD, FACS
10:50AMChemotherapy Redux: Resurrecting PCV
Chemotherapy for Oligodendroglioma
Jon Glass, MD
1:45PMApplication of Fiber-Optic Laser to
Malignant Intracranial Disease
Kevin D. Judy, MD, FACS
2:15PMReview of New Protocols for
Craniopharyngioma and WHO
Grade II Meningioma
Christopher J. Farrell, MD
3:00PMUtilization of Molecular Genetic Profiling Test
to Individualize Chemotherapy Treatment
Lyndon J. Kim, MD
3:30PMAnticipating the 2016 WHO Fascicle on Brain
Tumors: An Update
Lawrence C. Kenyon, MD, PhD
Nurse And Allied Health Professional Track:
Updates From Jefferson Nurses
ORCHESTRA BALLROOM
1:15PMWhen is a Novel Treatment Innovative and
When is it Experimental?
Catherine Harris, PhD, MBA, CRNP
1:45PMUpdate on Current Clinical Neuro-Oncology
Trials at Jefferson
Lauren Barbieri, CRNP
1:15PM
Break/Move to Breakout Session
3:30PMInteractive Discussion: Case Presentations
Two Afternoon Break-Out Sessions: Practicing
and Question/Answer
Physician Track and Nurses/Allied Health
Moderator: Lauren Barbieri, CRNP
Professionals Track. All attendees will re-convene Panelists: S akinah Abdulkhabir, RN, BSN
after the afternoon break-out sessions for the
Catherine Harris, PhD, MBA, CRNP
Closing Remarks in the Symphony Ballroom.
Gail Williams, DNP, CRNP, AOCNP
SYMPHONY BALLROOM
David W. Andrews, MD, FACS
James J. Evans, MD, FACS
Professor of Neurological Surgery
Vice Chair, Clinical Services
Department of Neurological Surgery
Division Chief, Division of Neuro-Oncology
Professor of Neurological Surgery and
Otolaryngology – Head and Neck Surgery
Director, Cranial Base and Pituitary Surgery
Co-Director, Jefferson Center for Minimally Invasive
Cranial Base and Endoscopic Neurosurgery
Lauren Barbieri, CRNP
Nurse Practitioner
Department of Neurological Surgery
FINAL PLENARY SESSION
4:00PMClosing Remarks
David W. Andrews, MD, FACS
1:15PMUpdate in Minimally Invasive Cranial
Base Surgery
James J. Evans, MD, FACS
For additional information please visit CME.Jefferson.edu
Kevin D. Judy, MD, FACS
Professor of Neurological Surgery
Section Chief, Surgical Neuro-Oncology
Guest Faculty
2:45PMBreak & Exhibits
2:15PMRadiation Therapy WBRT/SRS: Nursing
Overview of the Radiation Treatment
11:20AMPanel of Invited Speakers: A Discussion of
Methods for Brain Tumors
Selected Cases from the Faculty
Gail Williams, DNP, CRNP, AOCNP
Moderator: David W. Andrews, MD, FACS
Panelists: T racy T. Batchelor, MD, MPH
2:45PMBreak & Exhibits
Jason T. Huse, MD, PhD
Frederick F. Lang, Jr, MD, FACS, FAANS 3:00PMNursing Management of Patients with Brain
Tumors in Ambulatory Care
12:30PM Lunch & Exhibits
Sakinah Abdulkhabir, RN, BSN
Practicing Physician Track:
Updates From Jefferson Physicians
Sidney Kimmel Medical College Course Directors
Tracy T. Batchelor, MD, MPH
Giovanni Armenise - Harvard Professor of Neurology, Harvard Medical School
Executive Director, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital
Boston, Massachusetts
Jason T. Huse, MD, PhD
Assistant Member, Department of Pathology and Human Oncology and Pathogenis Program
Memorial Sloan-Kettering Cancer Center
New York, New York
Frederick F. Lang, Jr, MD, FACS, FAANS
Professor of Neurosurgery
Director of Clinical Research, Department of Neurosurgery, Division of Surgery
The University of Texas MD Anderson Cancer Center
Houston, TX
Sidney Kimmel Medical College Faculty
Sakinah Abdulkhabir, RN, BSN
Lawrence Kenyon, MD, PhD
Nurse, Department of Neurological Surgery
Associate Professor of Pathology, Anatomy,
Cell Biology, and Neurology
Christopher Farrell, MD
Associate Professor of Neurological Surgery
Lyndon Kim, MD
Jon Glass, MD
Associate Professor of Medical Oncology
and Neurological Surgery
Associate Professor of Neurology and Neurological Surgery
Catherine Harris, PhD, MBA, CRNP
Assistant Professor, Graduate Program
Jefferson College of Nursing
Gail Williams DNP, CRNP, AOCNP
Nurse Practitioner, Department of Neurological Surgery
For more information, please visit the course web page: CME.Jefferson.edu
ACCREDITATION INFORMATION
PHYSICIANS: Sidney Kimmel Medical College at Thomas
Jefferson University is accredited by the ACCME to
provide continuing medical education for physicians.
Sidney Kimmel Medical College designates this live activity
for a maximum of 6.75 AMA PRA Category 1 CreditsTM.
Physicians should claim only the credit commensurate
with the extent of their participation in the activity.
NURSES: Thomas Jefferson University Hospital is an approved
provider of continuing nursing education by the PA State
Nurses Association, an accredited approver by the American
Nurses Credentialing Center’s Commission on Accreditation.
A maximum of 6.66 contact hours will be awarded to
participants.
PHYSICIAN ASSISTANTS: The American Academy of
Physician Assistants accepts AMA PRA Category 1
Credit(s)™ (www.aapa.org).
FACULTY DISCLOSURE
All faculty participating in continuing medical education
activities sponsored by Sidney Kimmel Medical College
at Thomas Jefferson University are expected to disclose
to the activity audience any real or apparent conflict(s)
of interest related to the content of their presentation(s).
Full disclosure of faculty relationships will be made at the
activity.
HOTEL ACCOMMODATIONS
Please visit the course web page for hotel accommodation
information.
In keeping with Jefferson’s integrated approach to education and care, this Symposium is organized through the collaborative
efforts of Jefferson’s Sidney Kimmel Cancer Center, and Sidney Kimmel Medical College at Thomas Jefferson University.
5th Annual Brain Tumor Symposium
The New Revolution in Neuro-Oncology:
Molecular Diagnoses and Targeted Treatments
Friday, October 30, 2015 | DoubleTree by Hilton Hotel Philadelphia Center City
237 South Broad Street, Philadelphia, PA 19107
Course Description
This CME Conference offers participants a unique opportunity to hear expert clinician leaders relate
their knowledge of the field of neuro-oncology and current state-of-the-art advances. Cases will be
examined from multiple perspectives, providing participants with clinical pearls for diagnosing and
managing malignant brain tumors to improve patient outcomes.
The course will feature:
• M
orning lectures devoted to the theme of the symposium: new research initiatives that highlight
the dramatic advances in both diagnosis and treatment of malignant brain tumors.
Friday, October 30, 2015
(Preliminary Agenda/Subject to Change)
7:00AMRegistration, Continental Breakfast,
and Exhibits
7:45AMWelcome & Introduction of
Keynote Speakers
David W. Andrews, MD, FACS
Lyndon J. Kim, MD
8:00AM
Keynote Lecture: Exploiting Viruses and
Stem Cells for Glioma Therapy
Frederick F. Lang, Jr, MD, FACS, FAANS
Introduction: Kevin D. Judy, MD, FACS
8:40AM
• A
fternoon, profession-specific break-out sessions, providing additional opportunities for focused
discussions and interactions.
Each session will be designed to give practitioners updates in the latest trends and advances in
neuro-oncology and learning will be reinforced through lively interactive case-based discussion.
Lectures will also provide practitioners with updates in ongoing clinical trials at Jefferson as well as
current outpatient brain tumor management.
Educational Design
At the conclusion of this conference, participants should be able to:
ƒƒ Examine how viruses work and how they can
be engineered for glioma therapy.
ƒƒ Describe how molecular markers refine the
diagnosis and management of diffuse glioma
and evaluate their impact on both prognosis
and treatment.
ƒƒ Assess the plight of orphan diseases and the
challenges of establishing evidence-based
treatment data for small patient populations.
ƒƒ Appraise the literature and the WHO Classification
System for common brain tumors and cite
sources where new knowledge has modified or
changed the classification of certain tumors.
ƒƒ Recognize how molecular markers refine the
diagnosis and management of brain metastases ƒƒ Summarize the history of human experimentation
from systemic cancers and evaluate their
spanning from the mid-20th century to the
impact on both prognosis and treatment.
present and draw conclusions about evolution of
FDA regulations for human research.
ƒƒ Review and critique current treatment
strategies for CNS lymphoma and evaluate the ƒƒ Evaluate current clinical trials at Jefferson as it
metrics for establishing a cure for this disease.
relates to patient centric care and validate the
process for enrollment criteria for each trial.
ƒƒ Examine how the current standard of care
treatment negatively impacts the immune system ƒƒ Differentiate various radiation treatment methods
and how this might influence an immunotherapy
currently utilized for benign and malignant
treatment for recurrent glioma treatment.
disease and evaluate patient centric care needs,
both during and after radiation therapy.
ƒƒ Analyze the challenging anatomy of the sellar
region and appreciate how recent innovations ƒƒ Analyze the detailed nature of outpatient care
in treatment and outcomes have improved
of brain tumor patients and identify the tools to
patient care.
determine the individual needs of patients and
families, particularly during treatment.
ƒƒ Appraise the methodology and technology
of new fiberoptic laser technology and its
ƒƒ Assess their individual practice in light of the
application to challenging lesions such as
information and discussions during the course,
“butterfly” gliomas.
and identify specific strategies to implement as
part of a continuing improvement process for
their practices.
eynote Lecture: The Evolving Role of
K
Molecular Markers in the Diagnosis and
Management of Diffuse Gliomas
Jason T. Huse, MD, PhD
Keynote Lecture: Targeted Therapeutics
for Gliomas
Tracy T. Batchelor, MD, MPH
Introduction: Lyndon J. Kim, MD
9:20AM
10:00AMBreak & Exhibits
10:20AMUpdate for IND 14379-101: Immunotherapy
Trial for Recurrent Glioma
David W. Andrews, MD, FACS
10:50AMChemotherapy Redux: Resurrecting PCV
Chemotherapy for Oligodendroglioma
Jon Glass, MD
1:45PMApplication of Fiber-Optic Laser to
Malignant Intracranial Disease
Kevin D. Judy, MD, FACS
2:15PMReview of New Protocols for
Craniopharyngioma and WHO
Grade II Meningioma
Christopher J. Farrell, MD
3:00PMUtilization of Molecular Genetic Profiling Test
to Individualize Chemotherapy Treatment
Lyndon J. Kim, MD
3:30PMAnticipating the 2016 WHO Fascicle on Brain
Tumors: An Update
Lawrence C. Kenyon, MD, PhD
Nurse And Allied Health Professional Track:
Updates From Jefferson Nurses
ORCHESTRA BALLROOM
1:15PMWhen is a Novel Treatment Innovative and
When is it Experimental?
Catherine Harris, PhD, MBA, CRNP
1:45PMUpdate on Current Clinical Neuro-Oncology
Trials at Jefferson
Lauren Barbieri, CRNP
1:15PM
Break/Move to Breakout Session
3:30PMInteractive Discussion: Case Presentations
Two Afternoon Break-Out Sessions: Practicing
and Question/Answer
Physician Track and Nurses/Allied Health
Moderator: Lauren Barbieri, CRNP
Professionals Track. All attendees will re-convene Panelists: S akinah Abdulkhabir, RN, BSN
after the afternoon break-out sessions for the
Catherine Harris, PhD, MBA, CRNP
Closing Remarks in the Symphony Ballroom.
Gail Williams, DNP, CRNP, AOCNP
SYMPHONY BALLROOM
David W. Andrews, MD, FACS
James J. Evans, MD, FACS
Professor of Neurological Surgery
Vice Chair, Clinical Services
Department of Neurological Surgery
Division Chief, Division of Neuro-Oncology
Professor of Neurological Surgery and
Otolaryngology – Head and Neck Surgery
Director, Cranial Base and Pituitary Surgery
Co-Director, Jefferson Center for Minimally Invasive
Cranial Base and Endoscopic Neurosurgery
Lauren Barbieri, CRNP
Nurse Practitioner
Department of Neurological Surgery
FINAL PLENARY SESSION
4:00PMClosing Remarks
David W. Andrews, MD, FACS
1:15PMUpdate in Minimally Invasive Cranial
Base Surgery
James J. Evans, MD, FACS
For additional information please visit CME.Jefferson.edu
Kevin D. Judy, MD, FACS
Professor of Neurological Surgery
Section Chief, Surgical Neuro-Oncology
Guest Faculty
2:45PMBreak & Exhibits
2:15PMRadiation Therapy WBRT/SRS: Nursing
Overview of the Radiation Treatment
11:20AMPanel of Invited Speakers: A Discussion of
Methods for Brain Tumors
Selected Cases from the Faculty
Gail Williams, DNP, CRNP, AOCNP
Moderator: David W. Andrews, MD, FACS
Panelists: T racy T. Batchelor, MD, MPH
2:45PMBreak & Exhibits
Jason T. Huse, MD, PhD
Frederick F. Lang, Jr, MD, FACS, FAANS 3:00PMNursing Management of Patients with Brain
Tumors in Ambulatory Care
12:30PM Lunch & Exhibits
Sakinah Abdulkhabir, RN, BSN
Practicing Physician Track:
Updates From Jefferson Physicians
Sidney Kimmel Medical College Course Directors
Tracy T. Batchelor, MD, MPH
Giovanni Armenise - Harvard Professor of Neurology, Harvard Medical School
Executive Director, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital
Boston, Massachusetts
Jason T. Huse, MD, PhD
Assistant Member, Department of Pathology and Human Oncology and Pathogenis Program
Memorial Sloan-Kettering Cancer Center
New York, New York
Frederick F. Lang, Jr, MD, FACS, FAANS
Professor of Neurosurgery
Director of Clinical Research, Department of Neurosurgery, Division of Surgery
The University of Texas MD Anderson Cancer Center
Houston, TX
Sidney Kimmel Medical College Faculty
Sakinah Abdulkhabir, RN, BSN
Lawrence Kenyon, MD, PhD
Nurse, Department of Neurological Surgery
Associate Professor of Pathology, Anatomy,
Cell Biology, and Neurology
Christopher Farrell, MD
Associate Professor of Neurological Surgery
Lyndon Kim, MD
Jon Glass, MD
Associate Professor of Medical Oncology
and Neurological Surgery
Associate Professor of Neurology and Neurological Surgery
Catherine Harris, PhD, MBA, CRNP
Assistant Professor, Graduate Program
Jefferson College of Nursing
Gail Williams DNP, CRNP, AOCNP
Nurse Practitioner, Department of Neurological Surgery
For more information, please visit the course web page: CME.Jefferson.edu
ACCREDITATION INFORMATION
PHYSICIANS: Sidney Kimmel Medical College at Thomas
Jefferson University is accredited by the ACCME to
provide continuing medical education for physicians.
Sidney Kimmel Medical College designates this live activity
for a maximum of 6.75 AMA PRA Category 1 CreditsTM.
Physicians should claim only the credit commensurate
with the extent of their participation in the activity.
NURSES: Thomas Jefferson University Hospital is an approved
provider of continuing nursing education by the PA State
Nurses Association, an accredited approver by the American
Nurses Credentialing Center’s Commission on Accreditation.
A maximum of 6.66 contact hours will be awarded to
participants.
PHYSICIAN ASSISTANTS: The American Academy of
Physician Assistants accepts AMA PRA Category 1
Credit(s)™ (www.aapa.org).
FACULTY DISCLOSURE
All faculty participating in continuing medical education
activities sponsored by Sidney Kimmel Medical College
at Thomas Jefferson University are expected to disclose
to the activity audience any real or apparent conflict(s)
of interest related to the content of their presentation(s).
Full disclosure of faculty relationships will be made at the
activity.
HOTEL ACCOMMODATIONS
Please visit the course web page for hotel accommodation
information.
In keeping with Jefferson’s integrated approach to education and care, this Symposium is organized through the collaborative
efforts of Jefferson’s Sidney Kimmel Cancer Center, and Sidney Kimmel Medical College at Thomas Jefferson University.
5th Annual
Brain Tumor Symposium
PAID
PERMIT NO. #117
SOUTHEASTERN, PA
19399
The New Revolution in Neuro-Oncology:
Molecular Diagnoses and Targeted Treatments
NON-PROFIT ORG
U.S. POSTAGE
5th Annual Brain Tumor Symposium
Friday, October 30, 2015 | DoubleTree by Hilton Hotel Philadelphia Center City
237 South Broad Street, Philadelphia, PA 19107
The New Revolution in Neuro-Oncology:
Molecular Diagnoses and Targeted Treatments
Registration Fees
Practicing Physician
$165
Nurse / Nurse Practitioner
$140
Allied Health Professional
$140
Jefferson Affiliate Hospitals - Practicing Physician
$125
Jefferson Affiliate Hospitals - Nurse / Allied Health Professional
$105
Non-Jefferson Resident
$100
Non-Jefferson Fellow
$100
ATION
REGISTR
N OW !
OPEN
The registration fee includes all course materials, access to presentations online, CE certificate, breakfast,
refreshment breaks and lunch. The registration fee does not include parking.
HOME
CME ACTIVITIES
| Sidney Kimmel Medical College
RSS/GRAND ROUNDS
LEARNING GROUPS
CREDIT HISTORY
CONTACT US
*Registration Deadline is: October 28, 2015*
Registrations should be submitted online by this date. Registrations cannot be processed without payment.
Should you need additional assistance or if you have any special needs, please contact the Office of CME at
215-955-6992 or via email at jeffersoncme@Jefferson.edu. Paper registration available upon request.
Department of Neurological Surgery
As an integral part of Jefferson Hospital for Neuroscience, the region’s only dedicated hospital for neuroscience,
the Department of Neurological Surgery is one of the busiest academic neurosurgical programs in the country,
offering state-of-the-art treatment to patients with neurological diseases affecting the brain and spine, such
as brain tumors, spinal disease, vascular brain diseases, epilepsy, pain, Parkinson’s disease and many other
neurological disorders. Jefferson.edu/university/jmc/departments/neurosurgery.html
Registration Now Open!
Thomas Jefferson University
Register
Office of Continuing Medical Education
1020 Locust Street, Suite M-5
Philadelphia, PA 19107
Log in
Have a smart phone?
Go to scanlife.com
to download your free
QR code reader
Step #2 – Once you are logged in, you may register for this conference by clicking the “CME Activities” tab
located on the top of the page, and clicking on the activity name “5th Annual Brain Tumor Symposium”.
• Review the course webpage, and scroll down to see the registration options.
• Complete the online registration process.
• You will receive a confirmation email of your successful registration.
• If you are unable to attend, cancellation fees may be applied. Please refer to the Cancellation/Refund
Policy located on the course webpage at CME.Jefferson.edu.
Friday, October 30, 2015
Step #1 – Login to your account on CPD@JeffLearn™ at CME.Jefferson.edu.
• If you do not have an account, step by step instructions can be found on the CPD@JeffLearn™ webpage.
• Click “Login” if you have an account. Click “Register” to create an account
The New Revolution in Neuro-Oncology:
Molecular Diagnoses and Targeted Treatments
Important Browser Information – site works best on Google CHROME, Mozilla FIREFOX, SAFARI or OPERA.
Please be sure you are running the most recent version of your browser.
5th Annual Brain Tumor Symposium
Here’s How to Register Online Today at CME.Jefferson.edu:
Friday, October 30, 2015
DoubleTree by Hilton Hotel Philadelphia Center City
Featured Guest Speakers
Tracy T. Batchelor, MD, MPH
Jason T. Huse, MD, PhD
Frederick F. Lang, Jr, MD, FACS, FAANS